89bio, Inc. Share Price
NASDAQ: ETNB$0.00
+0.00 (0.00%) 89bio, Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
89bio, Inc. Share Price Chart
$0.00$0.00
L
H
89bio, Inc. Stock Fundamentals & Key Indicators
Market Cap N/A | PE Ratio (TTM) N/A | Dividend Yield N/A |
EPS (TTM) $-3.51 | Revenue (TTM) N/A | Return On Equity (TTM) -91.59% |
Profit Margin N/A | Debt to Equity 0.09 | Quarterly Earnings Growth YoY -132.44% |
89bio, Inc. Quarterly Profit & Loss
All figures in USD
89bio, Inc. Annual Profit & Loss
All figures in USD
About 89bio, Inc.
89bio, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of metabolic dysfunction-associated steatohepatitis and hypertriglyceridemia. The company was founded in 2018 and is headquartered in San Francisco, California.
89bio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|
ETNB Share Price FAQs
What is 89bio, Inc. share price today?
89bio, Inc. share price today is $0.00 as on August 11, 2026 at 10:55 am IST.
What is the 52 week high and 52 week low of 89bio, Inc. stock?
52 week high/low data for 89bio, Inc. is currently unavailable.
What is ETNB's net income for the last quarter?
ETNB's net income for the last quarter is -0.11B USD.
Can I buy ETNB shares in India?
Yes. You can buy ETNB in India by opening an international trading account.